Call to Schedule Free Consultation at Over 80 Centers Worldwide!

(844) GET-STEM

Is Birth Tissue Collection Safe for the Baby and Mother?

Written by Dr. David Greene, MD, PhD, MBA on May 25, 2026

Table of Contents

If you are exploring regenerative medicine treatments that use birth-derived tissues — such as umbilical cord stem cells or amniotic membrane — a natural first question is whether collecting these materials puts the baby or mother at risk.

The answer is no. Birth tissue collection is entirely safe for both. It requires no additional procedures, no changes to the birth plan, and no intervention during delivery. Here is what you need to know.

The Delivery Process Is Not Changed

Whether a mother delivers vaginally or by planned C-section, labor and delivery proceed exactly as they normally would. No extra steps are added. No additional incisions are made. The collection takes place only after the birth is complete and the umbilical cord has been clamped and cut — meaning the baby is fully separated and unaffected.

The materials collected — primarily the umbilical cord, its inner Wharton’s jelly, cord blood, or amniotic membrane — are items that would otherwise be discarded as medical waste. Their collection adds nothing to the experience for mother or newborn.

Consent Comes First

Ethical birth tissue collection is entirely consent-driven. Before delivery, the mother is fully informed about what will be collected, how it will be used, and by whom. She can decline at any point without any effect on her care.

This process is governed by FDA regulations covering Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Donor tissue must meet strict screening, processing, labeling, and storage requirements before it can be used therapeutically. You can learn more about the FDA’s regulatory framework for tissue products and how it protects both donors and patients.

What Happens After Collection

Once collected, the tissue is placed immediately into a sterile, sealed container and transported to a certified processing laboratory. From there, the process follows a tightly regulated chain:

Processing under sterile, Good Manufacturing Practice (GMP) conditions

Infectious disease screening for HIV, hepatitis B and C, and other pathogens

Cryopreservation and distribution to licensed healthcare providers

This ensures the final product is safe and viable for patients receiving regenerative treatments.

Cord Donation vs. Cord Blood Banking: An Important Distinction

Many families confuse donor tissue programs with private cord blood banking. They are not the same.

Private cord blood banking is a paid service where a family stores their newborn’s cord blood for potential future use by that child or family. Donor tissue collection is a separate, voluntary process where the mother consents to donate the cord tissue to a regulated supply chain for use in other patients — typically at no cost to the family.

Neither decision obligates the other. Families are free to choose either, both, or neither.

Why Birth Tissues Matter in Regenerative Medicine

Umbilical cord tissue — particularly Wharton’s jelly — is one of the richest known sources of mesenchymal stem cells (MSCs). Compared to MSCs harvested from adult donors (such as bone marrow or fat tissue), perinatal MSCs tend to be more biologically active because they come from younger tissue with less cellular aging.

These cells also carry immunoprivileged properties, meaning they can often be used in allogeneic (donor-to-patient) therapies without immune rejection. They release anti-inflammatory signals, growth factors, and other molecules that support tissue repair throughout the body.

Equally important, these tissues are sourced from materials that would otherwise be discarded — raising no ethical concerns about harm to a developing life.

To learn more about how these cells work, see R3 Stem Cell’s overview of umbilical cord tissue therapy and the advantages of mesenchymal stem cells in regenerative medicine.

Conditions Treated with Birth Tissue Therapies

Regenerative therapies using umbilical cord and amniotic tissue are applied across a wide range of conditions, including:

Joint and musculoskeletal disorders: knee arthritis , rotator cuff injuries , degenerative disc disease

Neurological conditions: ALS , multiple sclerosis , stroke recovery

Autoimmune disease: rheumatoid arthritis , lupus

Cardiovascular conditions: congestive heart failure , cardiomyopathy

R3 Stem Cell offers a free consultation to help patients determine whether they may be a candidate for regenerative therapy.

Conclusion

Birth tissue collection is safe, ethically grounded, and rigorously regulated. It places no burden on the mother, no risk on the newborn, and requires no deviation from normal delivery. The tissues collected — umbilical cord and amniotic membrane — provide some of the most therapeutically valuable biological materials available in regenerative medicine today.

For patients considering an alternative to surgery or long-term medication management, therapies derived from donated birth tissue offer a meaningful, evidence-informed option worth discussing with a qualified specialist.

Contact Us

Stem cell therapy for diabetes is not yet a standard of care in most countries and is generally considered investigational or complementary. Patients should review FDA regulations on cell therapies for context.

The Delivery Process Is Not Changed

Why Dr. Hector is "Passionate" About the Word "Natural"

Consent alone is not sufficient. Donor mothers also undergo comprehensive medical screening, which typically includes:

What Does the Bioethics Community Say?